Axel Mescheder
Algemeen Directeur bij Cristal Delivery BV
Profiel
Axel Mescheder is currently the Chief Executive & Medical Officer at Cristal Delivery BV since 2018.
Prior to this, he worked as the Director-Research & Development at MediGene AG, Chief Medical Officer at MorphoSys AG, and Chief Medical & Development Officer at Topotarget A.
He also worked as a Research Physician at the University of Cincinnati (Ohio).
Dr. Mescheder holds a doctorate degree from the University of Kiel.
Actieve functies van Axel Mescheder
Bedrijven | Functie | Begin |
---|---|---|
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Algemeen Directeur | 02-11-2018 |
Eerdere bekende functies van Axel Mescheder
Bedrijven | Functie | Einde |
---|---|---|
TOPOTARGET A/S | Hoofd Techniek/Wetenschap/O&O | 31-10-2012 |
MEDIGENE AG | Hoofd Techniek/Wetenschap/O&O | 15-09-2008 |
MORPHOSYS AG | Hoofd Techniek/Wetenschap/O&O | - |
University of Cincinnati (Ohio) | Corporate Officer/Principal | - |
Opleiding van Axel Mescheder
University of Kiel | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MEDIGENE AG | Health Technology |
MORPHOSYS AG | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Topotarget A/S
Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Health Technology |